• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911616250
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Chest Pain (1776); Reocclusion (1985)
Event Date 11/06/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
 
Event Description
(b)(6) clinical study.It was reported that chest discomfort and in-stent restenosis occurred.In (b)(6) 2013, the subject presented with silent ischemia and was diagnosed with stable angina.The subject was then referred for cardiac catheterization and the index procedure was performed on the same day.The target lesion was a de novo lesion located in the distal left circumflex artery (lcx) with 80% stenosis and was 12 mm long with a reference vessel diameter of 2.5 mm.It was treated with pre-dilatation and placement of a 2.50 x 16 mm promus element¿ plus study stent.Following post-dilatation, residual stenosis was 0%.On the same day, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2017, the subject presented with progressive accelerating exertional chest discomfort.Subsequently, the subject was hospitalized and coronary angiography was permed which revealed an 80% in-stent restenosis (isr) of the previously implanted 2.50 x 16 mm promus element¿ plus study stent in distal lcx.The stress test performed on the same day revealed distal, anterior, apical and posterolateral lateral wall ischemia.The subject was hospitalized and referred for cardiac catheterization.The 80% isr of distal lcx was treated with pre-dilation and placement of 2.25 x 32 mm synergy drug eluting stent within the previously placed proximal and distal stents.Following post-dilatation, residual stenosis was 0%.The following day, subject was discharged in stable ambulatory condition.
 
Manufacturer Narrative
Describe event or problem, relevant tests/lab data, other relevant history, and patient code updated.(b)(4).
 
Event Description
It was further reported that the patient had progressive angina and slight elevation of troponin.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7409162
MDR Text Key104762907
Report Number2134265-2018-02816
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729807360
UDI-Public08714729807360
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/22/2013
Device Model NumberH7493911616250
Device Catalogue Number39116-1625
Device Lot Number0015058086
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/16/2018
Initial Date FDA Received04/09/2018
Supplement Dates Manufacturer Received05/11/2018
Supplement Dates FDA Received06/05/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/15/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
-
-